The Break Up Big Medicine Act represents a comprehensive structural intervention in the healthcare industry designed to dismantle vertical integration between healthcare financing entities and service providers. The legislation targets the consolidation of pharmacy benefit managers, insurers, and pharmaceutical wholesalers with medical service providers and management services organizations. By mandating the separation of these commonly owned entities, the bill seeks to restore competitive market dynamics, reduce conflicts of interest, and prevent anticompetitive practices that may inflate healthcare costs and limit patient choice. The Act establishes a mandatory divestiture framework with strict timelines and robust enforcement mechanisms involving both federal antitrust authorities and state attorneys general. This represents a significant federal intervention into healthcare market structure, premised on congressional authority under the Commerce Clause to regulate interstate commerce in healthcare services and products.

What is the status of S3822?

Introduced as of February 10, 2026.

The Break Up Big Medicine Act represents a comprehensive structural intervention in the healthcare industry designed to dismantle vertical integration between healthcare financing entities and service providers. The legislation targets the consolidation of pharmacy benefit managers, insurers, and pharmaceutical wholesalers with medical service providers and management services organizations. By mandating the separation of these commonly owned entities, the bill seeks to restore competitive market dynamics, reduce conflicts of interest, and prevent anticompetitive practices that may inflate healthcare costs and limit patient choice. The Act establishes a mandatory divestiture framework with strict timelines and robust enforcement mechanisms involving both federal antitrust authorities and state attorneys general. This represents a significant federal intervention into healthcare market structure, premised on congressional authority under the Commerce Clause to regulate interstate commerce in healthcare services and products.

What is the status of S3822?

Introduced as of February 10, 2026.

S3822 U.S. Senate: Break Up Big Medicine Act

Introduced

S. 3822

Introduced in Senate · February 24, 2026

February 10, 2026

Ms. Warren (for herself and Mr. Hawley) introduced the following bill; which was read twice and referred to the Committee on the Judiciary

A BILL

To prohibit pharmacy benefit managers, insurers, and prescription drug or medical device wholesalers from being under common ownership with certain medical service providers, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Break Up Big Medicine Act”.

Introduced

S. 3822

Introduced in Senate · February 24, 2026

February 10, 2026

Ms. Warren (for herself and Mr. Hawley) introduced the following bill; which was read twice and referred to the Committee on the Judiciary

A BILL

To prohibit pharmacy benefit managers, insurers, and prescription drug or medical device wholesalers from being under common ownership with certain medical service providers, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Break Up Big Medicine Act”.

Introduced

S. 3822

Introduced in Senate · February 24, 2026

February 10, 2026

Ms. Warren (for herself and Mr. Hawley) introduced the following bill; which was read twice and referred to the Committee on the Judiciary

A BILL

To prohibit pharmacy benefit managers, insurers, and prescription drug or medical device wholesalers from being under common ownership with certain medical service providers, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Break Up Big Medicine Act”.

Introduced

S. 3822

Introduced in Senate · February 24, 2026

February 10, 2026

Ms. Warren (for herself and Mr. Hawley) introduced the following bill; which was read twice and referred to the Committee on the Judiciary

A BILL

To prohibit pharmacy benefit managers, insurers, and prescription drug or medical device wholesalers from being under common ownership with certain medical service providers, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Break Up Big Medicine Act”.

S.3822

S. 3822

S.3822

S. 3822

S.3822

S. 3822

S.3822

S. 3822